BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1986356)

  • 1. Soluble human CD4 elicits an antibody response in rhesus monkeys that inhibits simian immunodeficiency virus replication.
    Watanabe M; Chen ZW; Tsubota H; Lord CI; Levine CG; Letvin NL
    Proc Natl Acad Sci U S A; 1991 Jan; 88(1):120-4. PubMed ID: 1986356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization of simian immunodeficiency virus-infected rhesus monkeys with soluble human CD4 elicits an antiviral response.
    Watanabe M; Levine CG; Shen L; Fisher RA; Letvin NL
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4616-20. PubMed ID: 2052546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simian immunodeficiency virus inhibits bone marrow hematopoietic progenitor cell growth.
    Watanabe M; Ringler DJ; Nakamura M; DeLong PA; Letvin NL
    J Virol; 1990 Feb; 64(2):656-63. PubMed ID: 2296079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of viral RNA in CD4(-)CD8(-) and CD4(-)CD8(+) lymphocytes in vivo in rhesus monkeys infected with simian immunodeficiency virus of macaques.
    Huete JM; Chatis PA; Schmitz JE; Kuroda MJ; Letvin NL; Reimann KA
    AIDS Res Hum Retroviruses; 2001 Mar; 17(4):349-60. PubMed ID: 11242521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow monocyte/macrophages are an early cellular target of pathogenic and nonpathogenic isolates of simian immunodeficiency virus (SIVmac) in rhesus macaques.
    Mandell CP; Jain NC; Miller CJ; Dandekar S
    Lab Invest; 1995 Mar; 72(3):323-33. PubMed ID: 7898051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of recombinant human interleukin 12 to chronically SIVmac-infected rhesus monkeys.
    Watanabe N; Sypek JP; Mittler S; Reimann KA; Flores-Villanueva P; Voss G; Lord CI; Letvin NL
    AIDS Res Hum Retroviruses; 1998 Mar; 14(5):393-9. PubMed ID: 9546798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of recombinant soluble CD4 in rhesus monkeys infected with simian immunodeficiency virus of macaques.
    Watanabe M; Reimann KA; DeLong PA; Liu T; Fisher RA; Letvin NL
    Nature; 1989 Jan; 337(6204):267-70. PubMed ID: 2536140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A humanized, nondepleting anti-CD4 antibody that blocks virus entry inhibits virus replication in rhesus monkeys chronically infected with simian immunodeficiency virus.
    Reimann KA; Khunkhun R; Lin W; Gordon W; Fung M
    AIDS Res Hum Retroviruses; 2002 Jul; 18(11):747-55. PubMed ID: 12167266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo administration of CD4-specific monoclonal antibody: effect on provirus load in rhesus monkeys chronically infected with the simian immunodeficiency virus of macaques.
    Reimann KA; Cate RL; Wu Y; Palmer L; Olson D; Waite BC; Letvin NL; Burkly LC
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):517-25. PubMed ID: 7632466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gag-specific cytotoxic T lymphocytes in rhesus monkeys infected with the simian immunodeficiency virus of macaques.
    Miller MD; Lord CI; Stallard V; Mazzara GP; Letvin NL
    J Immunol; 1990 Jan; 144(1):122-8. PubMed ID: 2153161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo administration to rhesus monkeys of a CD4-specific monoclonal antibody capable of blocking AIDS virus replication.
    Reimann KA; Burkly LC; Burrus B; Waite BC; Lord CI; Letvin NL
    AIDS Res Hum Retroviruses; 1993 Mar; 9(3):199-207. PubMed ID: 8471310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A humanized form of a CD4-specific monoclonal antibody exhibits decreased antigenicity and prolonged plasma half-life in rhesus monkeys while retaining its unique biological and antiviral properties.
    Reimann KA; Lin W; Bixler S; Browning B; Ehrenfels BN; Lucci J; Miatkowski K; Olson D; Parish TH; Rosa MD; Oleson FB; Hsu YM; Padlan EA; Letvin NL; Burkly LC
    AIDS Res Hum Retroviruses; 1997 Jul; 13(11):933-43. PubMed ID: 9223409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential significance of the cellular immune response against the macaque strain of simian immunodeficiency virus (SIVMAC) in immunized and infected rhesus macaques.
    Voss G; Nick S; Stahl-Hennig C; Coulibaly C; Petry H; Lüke W; Hunsmann G
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2273-81. PubMed ID: 1357081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of anti-CD4 MAb hu5A8 for treatment of HIV-1 infection: preclinical assessment in non-human primates.
    Boon L; Holland B; Gordon W; Liu P; Shiau F; Shanahan W; Reimann KA; Fung M
    Toxicology; 2002 Apr; 172(3):191-203. PubMed ID: 11893418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo T-lymphocyte activation and transient reduction of viral replication in macaques infected with simian immunodeficiency virus.
    Chen ZW; Shen Y; Zhou D; Simon M; Kou Z; Lee-Parritz D; Shen L; Sehgal P; Letvin NL
    J Virol; 2001 May; 75(10):4713-20. PubMed ID: 11312343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmas from lymphocyte- and macrophage-tropic SIVmac-infected macaques have antibodies with a broader spectrum of virus neutralization activity in macrophage versus lymphocyte cultures.
    Zhuge W; Jia F; Adany I; Narayan O; Stephens EB
    Virology; 1997 Jan; 227(1):24-33. PubMed ID: 9007055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge.
    Dittmer U; Stahl-Hennig C; Coulibaly C; Nisslein T; Lüke W; Fuchs D; Bodemer W; Petry H; Hunsmann G
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1307-15. PubMed ID: 7782761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of complement consumption by cobra venom factor on the course of primary infection with simian immunodeficiency virus in rhesus monkeys.
    Schmitz JE; Lifton MA; Reimann KA; Montefiori DC; Shen L; Racz P; Tenner-Racz K; Ollert MW; Forman MA; Gelman RS; Vogel CW; Letvin NL
    AIDS Res Hum Retroviruses; 1999 Jan; 15(2):195-202. PubMed ID: 10029251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques.
    Demberg T; Florese RH; Heath MJ; Larsen K; Kalisz I; Kalyanaraman VS; Lee EM; Pal R; Venzon D; Grant R; Patterson LJ; Korioth-Schmitz B; Buzby A; Dombagoda D; Montefiori DC; Letvin NL; Cafaro A; Ensoli B; Robert-Guroff M
    J Virol; 2007 Apr; 81(7):3414-27. PubMed ID: 17229693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms for adaptation of simian immunodeficiency virus to replication in alveolar macrophages.
    Mori K; Rosenzweig M; Desrosiers RC
    J Virol; 2000 Nov; 74(22):10852-9. PubMed ID: 11044136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.